Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy

Abstract

The increased cumulative duration of metformin use decreased the recurrence, all-cause mortality, and cancer-specific mortality rates among GC patients with diabetes who underwent gastrectomy.